Collision 2023 – Fireside Talk with Lauren Pelley and BlueDot’s CEO
During Collision 2023’s HEALTH CONF, Lauren Pelley, a senior health reporter from CBC, sat down with BlueDot’s CEO and founder Dr. Kamran Khan to discuss
Read articleAlways be prepared with around-the-clock global surveillance of outbreaks & insights on the true burden of disease, and expert-produced risk assessments
Leverage diverse global data assets on disease spread, outbreak suitability, population vulnerability and more to make high-stakes decisions with confidence
Anticipate what’s coming in the weeks, months and even years ahead with disease forecasts
Safeguard your population against global outbreaks that can cause health, economic, and social disruption
Ensure your infectious disease countermeasures are deployed precisely where and when they are needed most
Protect your people, operations, supply chains and reputation from the disruptive effects of global outbreaks
Discover customer stories and real-world case studies showcasing how our intelligence informs actions and decisions
Explore our peer-reviewed scientific publications that advance knowledge on detecting, understanding, and controlling global outbreaks
Read about our achievements spanning scientific and technological innovation, business growth, and fostering a great work environment
Tune into our latest talks, webinars, and informative panel sessions to hear from global leaders engaging in thought provoking discussions while delving into pressing industry challenges
Access an array of valuable resources on the latest innovations in infectious disease intelligence
Stay up-to-date by engaging with our continuously updated collection of articles, insightful analyses, and diverse perspectives.
Our bi-monthly and monthly newsletters are your definitive source for the latest insights on infectious disease intelligence worldwide!
Stay current with the latest press from BlueDot, intelligence-related news, and industry-related updates
Learn about BlueDot’s founding story and how we’ve evolved to become the organization we are today
Meet the exceptional people who are the driving force behind our organization
We’d love to hear from you! Our philosophy is that our reach and impact in the world is extended by working with others who share our vision for a healthier, safer, and more resilient world!
During Collision 2023’s HEALTH CONF, Lauren Pelley, a senior health reporter from CBC, sat down with BlueDot’s CEO and founder Dr. Kamran Khan to discuss
Read articleAs part of Collision 2023’s GROWTH Summit track, BlueDot’s CEO and Founder, Dr. Kamran Khan, explores how the world is facing more frequent and severe
Read articleTORONTO, July 5, 2023 /PRNewswire-PRWeb/ — BlueDot Inc., a global leader in infectious disease intelligence, announced today that it has signed an agreement with the
Read articleEmpowering Chicago BlueDot enables the City of Chicago to make time sensitive, intelligence-driven decisions that protect their residents’ health and livelihoods. “The ability to pull
Read articleDiabetes emerges as a disturbing addition to the global burden While the World Health Organization may have lifted the global emergency status for COVID-19, the
Read articleEmpowering ChicagoBlueDot enables the City of Chicago to make time sensitive, intelligence-driven decisions that protect their residents’ health and livelihoods. “The ability to pull actionable
Read articleImagine a world where every outbreak is tracked as it emerges; where artificial intelligence and a data ecosystem help to pick up early signals and
Read articleTORONTO, ON, Canada — March 22, 2023 — BlueDot Inc., the leading artificial and human intelligence organization for detecting, assessing, and responding to global infectious diseases, today
Read articleEmpowering Chicago BlueDot enables the City of Chicago to make time sensitive, intelligence-driven decisions that protect their residents’ health and livelihoods. “The ability to pull
Read articleThe investment will support the company in product innovation and adoption while deepening its expansion into the private sector TORONTO, Canada, January 11, 2023, —
Read article